Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$32.09 - $37.51 $25,126 - $29,370
-783 Reduced 7.0%
10,397 $344,000
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $2,853 - $3,301
79 Added 0.71%
11,180 $410,000
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $4,096 - $5,333
104 Added 0.95%
11,101 $452,000
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $3,423 - $4,469
82 Added 0.75%
10,997 $563,000
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $2,800 - $3,418
64 Added 0.59%
10,915 $478,000
Q2 2022

Aug 03, 2022

SELL
$46.53 - $55.17 $6,979 - $8,275
-150 Reduced 1.36%
10,851 $569,000
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $3,980 - $4,932
87 Added 0.8%
11,001 $570,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $4,132 - $6,125
100 Added 0.92%
10,914 $644,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $76,537 - $98,319
-1,950 Reduced 15.28%
10,814 $465,000
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $3,447 - $3,905
96 Added 0.76%
12,764 $500,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $49,933 - $56,315
-1,491 Reduced 10.53%
12,668 $459,000
Q4 2020

Feb 23, 2021

BUY
$33.47 - $42.56 $24,399 - $31,026
729 Added 5.43%
14,159 $521,000
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $2,667 - $3,129
84 Added 0.63%
13,430 $493,000
Q2 2020

Aug 03, 2020

BUY
$30.12 - $36.54 $401,981 - $487,662
13,346 New
13,346 $436,000
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $160,071 - $228,707
-5,922 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$32.92 - $37.36 $194,952 - $221,245
5,922 New
5,922 $232,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $231,037 - $253,833
-6,161 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $2,308 - $2,631
-60 Reduced 0.96%
6,161 $269,000
Q3 2018

Nov 01, 2018

SELL
$34.47 - $41.81 $3,205 - $3,888
-93 Reduced 1.47%
6,221 $276,000
Q2 2018

Jul 27, 2018

BUY
$32.98 - $35.16 $208,235 - $222,000
6,314 New
6,314 $229,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Riverpoint Wealth Management Holdings, LLC Portfolio

Follow Riverpoint Wealth Management Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverpoint Wealth Management Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverpoint Wealth Management Holdings, LLC with notifications on news.